Kyntra Bio, Inc. SEC filings KYNB

Kyntra Bio, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 18, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (listing notice). The company's fiscal year ends on December 31.

Kyntra Bio, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 6, 2026 Oct 1, 2026
3 Initial insider ownership Oct 6, 2026 Oct 1, 2026
8-K Current report
Listing notice
Oct 6, 2026 Sep 30, 2026
8-K Current report
Officer or director change
Oct 1, 2026 Sep 30, 2026
4 Insider transaction Sep 9, 2026 Sep 6, 2026
4 Insider transaction Sep 9, 2026 Sep 6, 2026
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Aug 31, 2026 Aug 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
4 Insider transaction Jun 17, 2026 Jun 12, 2026
4 Insider transaction Jun 17, 2026 Jun 12, 2026
4 Insider transaction Jun 17, 2026 Jun 12, 2026
4 Insider transaction Jun 17, 2026 Jun 12, 2026
8-K Current report
Shareholder vote results
Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 9, 2026 Jun 6, 2026
4 Insider transaction Jun 9, 2026 Jun 6, 2026
8-K Current report
Other events
Jun 9, 2026 Jun 2, 2026
4/A Filing May 19, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 27, 2026 —
DEF 14A Proxy statement Apr 27, 2026 Jun 12, 2026
8-K Current report
Listing notice
Apr 9, 2026 Apr 2, 2026
10-K Annual report Mar 16, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 16, 2026 Mar 16, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
8-K Current report
Bylaw or fiscal year change, Other events
Jan 7, 2026 Jan 7, 2026
4 Insider transaction Dec 9, 2025 Dec 6, 2025
4 Insider transaction Dec 9, 2025 Dec 6, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
8-K Current report
Other events
Nov 6, 2025 Nov 6, 2025
4 Insider transaction Sep 9, 2025 Jun 6, 2025
4 Insider transaction Sep 9, 2025 Jun 6, 2025
8-K Current report
Acquisition or sale of assets
Sep 5, 2025 Aug 29, 2025
8-K Current report
Other events
Sep 2, 2025 Aug 29, 2025
8-K Current report
Other events
Aug 18, 2025 Aug 18, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 15, 2025 —
8-K Current report
Material agreement
Aug 14, 2025 Aug 12, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
8-K Current report
Material agreement
Jul 14, 2025 Jul 14, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
8-K Current report
Agreement ended
Jun 13, 2025 Jun 12, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jun 12, 2025 Jun 10, 2025
8-K Current report
Material agreement, Officer or director change, Shareholder vote results
Jun 9, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
3 Initial insider ownership Jun 6, 2025 Jun 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 4, 2025
PRE 14A Preliminary proxy statement Apr 17, 2025 Jun 4, 2025
8-K Current report
Bylaw or fiscal year change
Apr 4, 2025 Apr 2, 2025
8-K Current report
Regulation FD disclosure
Mar 31, 2025 Mar 28, 2025
8-K Current report
Material agreement
Mar 28, 2025 Mar 28, 2025
4 Insider transaction Mar 25, 2025 Mar 24, 2025
4 Insider transaction Mar 24, 2025 Mar 20, 2025
10-K Annual report Mar 17, 2025 Dec 31, 2024
8-K Current report
Results of operations, Listing notice
Mar 17, 2025 Mar 12, 2025
4 Insider transaction Mar 7, 2025 Mar 6, 2025
4 Insider transaction Mar 7, 2025 Mar 6, 2025
4 Insider transaction Mar 7, 2025 Mar 6, 2025
8-K Current report
Material agreement
Feb 24, 2025 Feb 24, 2025
424B5 Prospectus supplement Feb 24, 2025 —
8-K Current report
Material agreement, Results of operations, Officer or director change, Regulation FD disclosure
Feb 20, 2025 Feb 19, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
4 Insider transaction Jan 10, 2025 Jan 9, 2025
4 Insider transaction Jan 10, 2025 Jan 9, 2025
3 Initial insider ownership Dec 18, 2024 Dec 16, 2024
8-K Current report
Officer or director change
Dec 16, 2024 Dec 16, 2024
4 Insider transaction Dec 9, 2024 Dec 6, 2024
4 Insider transaction Dec 9, 2024 Dec 6, 2024
4 Insider transaction Dec 9, 2024 Dec 6, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
8-K Current report
Agreement ended
Oct 3, 2024 Sep 27, 2024
8-K Current report
Listing notice
Sep 16, 2024 Sep 12, 2024
8-K Current report
Officer or director change
Sep 13, 2024 Sep 12, 2024
4 Insider transaction Sep 9, 2024 Sep 6, 2024
4 Insider transaction Sep 9, 2024 Sep 6, 2024
4 Insider transaction Sep 9, 2024 Sep 6, 2024
8-K Current report
Officer or director change
Sep 6, 2024 Aug 30, 2024
S-8 Employee stock plan registration Aug 7, 2024 —
8-K Current report
Exit or restructuring costs
Aug 7, 2024 Aug 2, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
EFFECT Filing Jul 10, 2024 —
CORRESP Letter to the SEC Jul 9, 2024 —
UPLOAD Letter from the SEC Jul 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jul 8, 2024 —
S-3 Shelf registration Jun 28, 2024 —
8-K Current report
Other events
Jun 26, 2024 Jun 26, 2024
4 Insider transaction Jun 25, 2024 Jun 22, 2024
4 Insider transaction Jun 13, 2024 Jun 12, 2024
4 Insider transaction Jun 10, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
8-K Current report
Shareholder vote results
Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
10-Q Quarterly report May 6, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 6, 2024 May 6, 2024
4 Insider transaction May 2, 2024 May 1, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 24, 2024 —
DEF 14A Proxy statement Apr 24, 2024 Jun 5, 2024
3 Initial insider ownership Apr 24, 2024 Apr 22, 2024
4 Insider transaction Mar 25, 2024 Mar 22, 2024
4 Insider transaction Mar 11, 2024 Mar 7, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
10-K Annual report Feb 26, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 26, 2024 Feb 26, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
4 Insider transaction Feb 5, 2024 Feb 1, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 26, 2024 —
4 Insider transaction Dec 26, 2023 Dec 22, 2023
4 Insider transaction Dec 11, 2023 Dec 6, 2023
4 Insider transaction Dec 11, 2023 Dec 6, 2023
4 Insider transaction Dec 11, 2023 Dec 6, 2023
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 6, 2023 Nov 6, 2023
4 Insider transaction Nov 3, 2023 Nov 1, 2023
8-K Current report
Listing notice
Oct 27, 2023 Oct 24, 2023
8-K Current report
Officer or director change
Oct 6, 2023 Oct 2, 2023
4 Insider transaction Sep 25, 2023 Sep 22, 2023
4 Insider transaction Sep 8, 2023 Sep 6, 2023
4 Insider transaction Sep 8, 2023 Sep 6, 2023
4 Insider transaction Sep 8, 2023 Sep 6, 2023
4 Insider transaction Sep 8, 2023 Sep 6, 2023
4 Insider transaction Sep 6, 2023 Sep 1, 2023
4 Insider transaction Sep 6, 2023 Sep 1, 2023
8-K Current report
Officer or director change
Sep 6, 2023 Aug 31, 2023
4 Insider transaction Sep 1, 2023 Aug 30, 2023
4 Insider transaction Sep 1, 2023 Aug 30, 2023
144 Notice of proposed sale Sep 1, 2023 —
8-K Current report
Other events
Aug 29, 2023 Aug 29, 2023
4 Insider transaction Aug 14, 2023 Aug 10, 2023
4 Insider transaction Aug 9, 2023 Aug 7, 2023
4 Insider transaction Aug 8, 2023 Aug 4, 2023
S-8 Employee stock plan registration Aug 7, 2023 —
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 7, 2023 Aug 7, 2023
144 Notice of proposed sale Aug 4, 2023 —
8-K Current report
Officer or director change, Other events
Jul 25, 2023 Jul 21, 2023
SC 13G Ownership over 5% (passive) Jul 19, 2023 —
8-K Current report
Exit or restructuring costs
Jul 19, 2023 Jul 14, 2023
4 Insider transaction Jul 13, 2023 Jul 11, 2023
144 Notice of proposed sale Jul 11, 2023 —
4 Insider transaction Jul 10, 2023 Jul 7, 2023
4 Insider transaction Jun 26, 2023 Jun 23, 2023
8-K Current report
Other events
Jun 26, 2023 Jun 26, 2023
144 Notice of proposed sale Jun 23, 2023 —
4/A Form 4/a submission Jun 22, 2023 Jun 7, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
144 Notice of proposed sale Jun 13, 2023 —
144 Notice of proposed sale Jun 9, 2023 —
144 Notice of proposed sale Jun 9, 2023 —
144 Notice of proposed sale Jun 9, 2023 —
144 Notice of proposed sale Jun 9, 2023 —
4 Insider transaction Jun 9, 2023 Jun 7, 2023
4 Insider transaction Jun 9, 2023 Jun 7, 2023
4 Insider transaction Jun 9, 2023 Jun 7, 2023
4 Insider transaction Jun 9, 2023 Jun 7, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KYNB (Nasdaq)
Fiscal year ends
December 31
Headquarters
San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
921299
Former names
FIBROGEN INC (until Jan 7, 2026)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.